Search

everythinglearnresearchcommunity

for

Search:↓

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Finasteride, a medication, is being re-evaluated for its effects and uses.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.